ATE356838T1 - Biosynthetische matrix und deren verwendung - Google Patents

Biosynthetische matrix und deren verwendung

Info

Publication number
ATE356838T1
ATE356838T1 AT03783866T AT03783866T ATE356838T1 AT E356838 T1 ATE356838 T1 AT E356838T1 AT 03783866 T AT03783866 T AT 03783866T AT 03783866 T AT03783866 T AT 03783866T AT E356838 T1 ATE356838 T1 AT E356838T1
Authority
AT
Austria
Prior art keywords
matrix
bio
vivo
synthetic
polymer
Prior art date
Application number
AT03783866T
Other languages
English (en)
Inventor
May Griffith
David J Carlsson
Fengfu Li
Original Assignee
Ottawa Health Research Inst
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ottawa Health Research Inst, Ca Nat Research Council filed Critical Ottawa Health Research Inst
Application granted granted Critical
Publication of ATE356838T1 publication Critical patent/ATE356838T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/10—Hair or skin implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/142—Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F246/00—Copolymers in which the nature of only the monomers in minority is defined

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT03783866T 2002-08-09 2003-08-11 Biosynthetische matrix und deren verwendung ATE356838T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2397379 2002-08-09

Publications (1)

Publication Number Publication Date
ATE356838T1 true ATE356838T1 (de) 2007-04-15

Family

ID=31501599

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03783866T ATE356838T1 (de) 2002-08-09 2003-08-11 Biosynthetische matrix und deren verwendung

Country Status (12)

Country Link
US (3) US20060134050A1 (de)
EP (2) EP1530600B1 (de)
JP (2) JP2006516038A (de)
KR (1) KR101053792B1 (de)
CN (1) CN100491424C (de)
AT (1) ATE356838T1 (de)
AU (1) AU2003254674A1 (de)
BR (1) BR0313726A (de)
DE (1) DE60312525T2 (de)
ES (1) ES2283849T3 (de)
MX (1) MXPA05001570A (de)
WO (1) WO2004014969A1 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050042819A (ko) * 2002-09-13 2005-05-10 오큘라 사이언시즈, 인크. 시력 개선 장치 및 방법
US20040120982A1 (en) * 2002-12-19 2004-06-24 Zanini Diana Biomedical devices with coatings attached via latent reactive components
TWI354021B (en) * 2002-12-23 2011-12-11 Alcon Inc Compositions and methods for inhibiting protein on
US7628810B2 (en) 2003-05-28 2009-12-08 Acufocus, Inc. Mask configured to maintain nutrient transport without producing visible diffraction patterns
US20050046794A1 (en) 2003-06-17 2005-03-03 Silvestrini Thomas A. Method and apparatus for aligning a mask with the visual axis of an eye
KR101045438B1 (ko) * 2004-03-31 2011-06-30 톳쿄기쥬츠 가이하츠 가부시키가이샤 상피계 세포증식 촉진제
CN1972643A (zh) 2004-05-20 2007-05-30 库柏维景公司 用于提高视力的角膜覆盖物和波前像差矫正
EP1791499A4 (de) * 2004-08-13 2011-08-17 Ottawa Health Research Inst Die sehkraft verbessernde ophthalmische vorrichtungen und relevante verfahren und zusammensetzungen
US8246569B1 (en) 2004-08-17 2012-08-21 California Institute Of Technology Implantable intraocular pressure drain
KR101159071B1 (ko) * 2005-01-14 2012-06-26 삼성전자주식회사 신규한 히드로겔 공중합체, 상기 공중합체가 코팅되어있는 기판, 상기 공중합체를 이용하여 마이크로어레이를제조하는 방법 및 그에 의하여 제조된 마이크로어레이
US9999497B2 (en) * 2005-01-31 2018-06-19 Yichieh Shiuey Corneal implants and methods and systems for placement
US7976577B2 (en) * 2005-04-14 2011-07-12 Acufocus, Inc. Corneal optic formed of degradation resistant polymer
US20070148246A1 (en) * 2005-08-11 2007-06-28 Dan Luo Nucleic Acid-Based Matrixes
CN101305052B (zh) * 2005-09-09 2012-10-10 渥太华健康研究所 互穿网络和相关方法及组合物
JP2007126490A (ja) * 2005-11-01 2007-05-24 Univ Of Tokushima アミド基含有高分子化合物およびその製造方法
EP2319558B1 (de) 2006-03-14 2014-05-21 University Of Southern California Mems-Vorrichtung zur Wirkstofffreisetzung
US7883520B2 (en) 2006-04-10 2011-02-08 Forsight Labs, Llc Corneal epithelial pocket formation systems, components and methods
US8889791B2 (en) * 2006-10-10 2014-11-18 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Thermoresponsive, biodegradable, elastomeric material
MX2009006369A (es) 2006-12-15 2010-02-24 Lifebond Ltd Apositos y selladores hemostaticos de gelatina-transglutaminasa.
US20080274054A1 (en) * 2007-05-01 2008-11-06 Taipei Veterans General Hospital Composite for Thermo-Sensitive Cell-Tissue Transplanted Scaffold and Use thereof
US20100178316A1 (en) * 2007-05-30 2010-07-15 Anuj Chauhan Extended release of bioactive molecules from silicone hydrogels
US8252607B2 (en) * 2007-06-06 2012-08-28 Gautam Gupta Bio-compatible hybrid organic/inorganic gels: vapor phase synthesis
CA2691787A1 (en) * 2007-06-29 2009-01-08 The Trustees Of The University Of Pennsylvania Soft gel systems in modulating stem cell development
US8075909B2 (en) * 2007-09-04 2011-12-13 University Of Florida Research Foundation, Incorporated Contact lens based bioactive agent delivery system
JP5387850B2 (ja) * 2007-09-12 2014-01-15 Ｊｓｒ株式会社 タンパク安定化剤およびその製造方法、タンパク安定化剤の使用方法、ならびにタンパク安定化方法
WO2009042768A1 (en) * 2007-09-25 2009-04-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Triggerably dissolvable hollow fibers for controlled delivery
CN101396569B (zh) * 2007-09-27 2013-04-10 北京师范大学 以生物体组织为支架的复合水凝胶、其制备方法及其用途
US8293510B2 (en) * 2007-11-16 2012-10-23 University Of Kansas Method of preparing a hydrogel network encapsulating cells
EP2666510B1 (de) 2007-12-20 2017-10-18 University Of Southern California Vorrichtung zur kontrollierten Abgabe von Therapeutika
EP2727616B1 (de) 2008-01-03 2017-04-26 University Of Southern California Implantierbare Wirkstofffreisetzungsvorrichtungen sowie Geräte und Verfahren zum Auffüllen der Vorrichtungen
CN105400735A (zh) * 2008-01-30 2016-03-16 阿斯特利亚斯生物治疗股份公司 用于培养干细胞衍生的心肌细胞的合成表面
WO2009099539A2 (en) * 2008-01-30 2009-08-13 Corning Incorporated (meth)acrylate surfaces for cell culture, methods of making and using the surfaces
US8329469B2 (en) * 2008-01-30 2012-12-11 Geron Corporation Swellable (meth)acrylate surfaces for culturing cells in chemically defined media
KR20110007600A (ko) * 2008-01-30 2011-01-24 제론 코포레이션 세포배양 제품 및 스크리닝하는 방법
US8513009B2 (en) 2008-01-30 2013-08-20 Geron Corporation Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
WO2009102952A2 (en) * 2008-02-13 2009-08-20 Hyperbranch Medical Technology, Inc. Crosslinked polyalkyleneimine hydrogels with tunable degradation rates
FR2927902B1 (fr) * 2008-02-26 2011-11-11 Oreal Polymere ethylenique statistique comprenant un groupe reactif et un groupe ionisable, composition cosmetique et procede de traitement cosmetique.
US9943401B2 (en) 2008-04-04 2018-04-17 Eugene de Juan, Jr. Therapeutic device for pain management and vision
US8083347B2 (en) * 2008-04-29 2011-12-27 Ocugenics, LLC Drug delivery system and methods of use
US8361492B2 (en) * 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
WO2009137777A2 (en) 2008-05-08 2009-11-12 Replenish Pumps, Llc Implantable drug-delivery devices, and apparatus and methods for filling the devices
US9333297B2 (en) 2008-05-08 2016-05-10 Minipumps, Llc Drug-delivery pump with intelligent control
CN102202719B (zh) 2008-05-08 2014-11-26 迷你泵有限责任公司 可植入泵和用于可植入泵的插管
EP2323716B1 (de) 2008-05-08 2015-03-04 MiniPumps, LLC Arzneiabgabepumpen
US9694055B2 (en) * 2008-05-09 2017-07-04 Wake Forest University Health Sciences Renal tissue regeneration
CN104031393B (zh) 2008-06-18 2017-08-01 生命连结有限公司 改进的交联组合物
US20100080840A1 (en) * 2008-07-31 2010-04-01 Michael Cho Hybrid superporous hydrogel scaffold for cornea regeneration
WO2010019769A1 (en) * 2008-08-15 2010-02-18 The Trustees Of The University Of Pennsylvania Cross-linked polymer network formed by sequential cross-linking
FR2938544B1 (fr) * 2008-11-20 2011-01-21 Univ Cergy Pontoise Materiaux sous forme de reseaux interpenetres de polymeres associant un gel de fibrine et un reseau de polyethylene glycol
US8109997B2 (en) * 2009-01-18 2012-02-07 Eyeon Medical Ltd. Hydrophobic pseudo-endothelial implants for treating corneal edema
CN101543642B (zh) * 2009-04-02 2012-06-27 天津大学 胶原基互穿聚合物网络组织工程角膜替代物及其制备方法
WO2010127254A2 (en) * 2009-04-30 2010-11-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Thermoresponsive, biodegradable, elastomeric material and uses therefor
US8362144B2 (en) * 2009-05-21 2013-01-29 Corning Incorporated Monomers for making polymeric cell culture surface
WO2011005974A2 (en) * 2009-07-08 2011-01-13 Northwestern University Interpenetrating biomaterial matrices and uses thereof
US10004593B2 (en) 2009-08-13 2018-06-26 Acufocus, Inc. Intraocular lens with elastic mask
RU2012108951A (ru) 2009-08-13 2013-09-20 Акуфокус, Инк. Скрытые интраокулярные имплантанты и линзы
WO2011020074A1 (en) 2009-08-13 2011-02-17 Acufocus, Inc. Corneal inlay with nutrient transport structures
KR101697388B1 (ko) 2009-08-18 2017-01-17 미니펌프스, 엘엘씨 적응 제어기를 갖춘 전해 약품 운반 펌프
US9498385B2 (en) 2009-10-23 2016-11-22 Nexisvision, Inc. Conformable therapeutic shield for vision and pain
WO2011050327A1 (en) 2009-10-23 2011-04-28 Forsight Labs Llc Corneal denervation for treatment of ocular pain
JP5796860B2 (ja) 2009-12-22 2015-10-21 ライフボンド リミテッドＬｉｆｅｂｏｎｄ Ｌｔｄ 架橋マトリックスの特性を調節するための酵素的架橋剤の改変
JP5835693B2 (ja) * 2010-02-05 2015-12-24 株式会社角膜再生研究所 角膜内皮細胞の培養方法、移植用角膜内皮細胞シートの製造方法および角膜内皮細胞培養キット
WO2011105724A2 (ko) * 2010-02-24 2011-09-01 주식회사 티이바이오스 관절연골 재생용 지지체 및 이의 제조방법
EP2600910B1 (de) 2010-08-05 2016-01-20 Lifebond Ltd Wundverbände mit einer trockenzusammung und haftstoffe
WO2012021814A2 (en) 2010-08-13 2012-02-16 Wake Forest University Health Sciences Methods for making a tissue engineered muscle repair (temr) construct in vitro for implantation in vivo
WO2012024390A2 (en) 2010-08-17 2012-02-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biohybrid composite scaffold
EP3427693B1 (de) 2010-09-30 2020-06-24 KeraMed, Inc. Reversibel verformbare künstliche hornhaut
US9175153B2 (en) 2011-03-08 2015-11-03 The Johns Hopkins University Cellulose hydrogel compositions and contact lenses for corneal applications
US9211256B2 (en) 2011-03-08 2015-12-15 The Johns Hopkins University Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof
US8871016B2 (en) 2011-08-03 2014-10-28 The Johns Hopkins University Cellulose-based hydrogels and methods of making thereof
US9919099B2 (en) 2011-03-14 2018-03-20 Minipumps, Llc Implantable drug pumps and refill devices therefor
US10286146B2 (en) 2011-03-14 2019-05-14 Minipumps, Llc Implantable drug pumps and refill devices therefor
US9603997B2 (en) 2011-03-14 2017-03-28 Minipumps, Llc Implantable drug pumps and refill devices therefor
WO2014210186A2 (en) 2013-06-26 2014-12-31 Nexisvision, Inc. Contact lenses for refractive correction
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
WO2013082545A1 (en) 2011-12-02 2013-06-06 Acufocus, Inc. Ocular mask having selective spectral transmission
CN103204971B (zh) * 2013-01-16 2014-12-10 北京科技大学 基于硝基苯的三重响应聚合物自组装体的制备方法和应用
RU2513838C1 (ru) * 2013-02-21 2014-04-20 Общество с ограниченной ответственностью "ДЖИ-Групп" Гистоэквивалент-биопластический материал
US9204962B2 (en) 2013-03-13 2015-12-08 Acufocus, Inc. In situ adjustable optical mask
US9427922B2 (en) 2013-03-14 2016-08-30 Acufocus, Inc. Process for manufacturing an intraocular lens with an embedded mask
EP3011383A4 (de) 2013-06-20 2016-11-30 Mercy Medical Res Inst Kontaktlinsen mit verzögerter wirkstofffreisetzung und verfahren zur herstellung
US9512279B2 (en) * 2013-12-18 2016-12-06 Universite Cegy-Pontoise Interpenetrating polymer network
US10240122B2 (en) 2014-02-14 2019-03-26 Nissan Chemical Industries, Ltd. Active-ester-group-containing composition for producing fibers, and cell culture scaffold material using fibers produced from active-ester-group-containing composition
US20150290362A1 (en) * 2014-04-10 2015-10-15 Georgia Tech Research Corporation Hybrid fibrin-microgel constructs for tissue repair and regeneration
US10589002B2 (en) 2014-04-14 2020-03-17 University of Pittsburgh—of the Commonwealth System of Higher Education Biodegradable, thermally responsive injectable hydrogel for treatment of ischemic cardiomyopathy
KR101536134B1 (ko) 2014-09-26 2015-07-14 세원셀론텍(주) 연부조직 수복용 매트릭스의 제조방법
US10265438B1 (en) * 2014-11-03 2019-04-23 BioDlogics, LLC Methods and compositions for the repair and replacement of connective tissue
EP3220859B8 (de) 2014-11-19 2020-06-10 AcuFocus, Inc. Brechbare maske zur behandlung von presbyopie
WO2016100500A1 (en) * 2014-12-16 2016-06-23 The Regents Of The University Of Colorado, A Body Corporate Antimicrobial translimbal drainage device with replaceable filter
US11220669B2 (en) 2015-06-05 2022-01-11 Amolifescience Co., Ltd. Defined three dimensional microenvironment for cell culture
ES2972581T3 (es) 2015-10-05 2024-06-13 Acufocus Inc Métodos de moldeo de lentes intraoculares
EP3384342B1 (de) 2015-11-24 2021-08-25 AcuFocus, Inc. Torische intraokularlinse mit kleiner apertur und erweiterter tiefenschärfe
WO2017176930A1 (en) * 2016-04-08 2017-10-12 Emory University Diphenylacrylic acid derivatives that promote bone and cartilage growth
US11382862B2 (en) * 2017-11-16 2022-07-12 University of Pittsburgh—of the Commonwealth System of Higher Education Gel for treating periocular and/or orbital pathologies and conditions
US11364110B2 (en) 2018-05-09 2022-06-21 Acufocus, Inc. Intraocular implant with removable optic
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
KR102118807B1 (ko) * 2018-11-26 2020-06-03 숭실대학교산학협력단 3차원 오가노이드 제조용 형상변화형 하이드로젤 몰드 조성물 및 이를 통해 제조된 몰드
US11864990B2 (en) 2019-02-26 2024-01-09 Avedro, Inc. Bioresorbable corneal implants
CN110292657A (zh) * 2019-08-12 2019-10-01 郑州大学第一附属医院 一种用于组织修复的生物胶囊及其构建方法
KR20220084141A (ko) 2019-10-21 2022-06-21 엠아이피 다이어그노스틱스 리미티드 열 반응성 접합체
CN110694101A (zh) * 2019-11-25 2020-01-17 高敏楠 医用伤口组织止血修复细胞胶水与胶带组合及方法
CN112778474B (zh) * 2020-12-28 2022-07-19 中国科学院苏州生物医学工程技术研究所 用于流式细胞术的稀土笼状配位物金属荧光双模标签及制备方法
CN115144380B (zh) * 2022-07-21 2024-08-09 清华大学 细胞牵引力的测量方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452925A (en) * 1981-02-09 1984-06-05 National Patent Development Corporation Biologically stabilized compositions comprising collagen as the minor component with ethylenically unsaturated compounds used as contact lenses
US4780409A (en) * 1985-05-02 1988-10-25 Genetic Systems Corporation Thermally induced phase separation immunoassay
US4835235A (en) * 1986-01-24 1989-05-30 Hoechst Celanese Corporation Polyvinyl polymers exhibiting nonlinear optical response
DE3626160A1 (de) * 1986-08-01 1988-02-04 Basf Ag Leimungsmittel fuer papier auf basis von fettalkyldiketenen und kationischen polyacrylamiden und terpolymerisate aus acrylamid, n-vinylimidazol und n-vinylimidazolin
US5653725A (en) * 1990-07-12 1997-08-05 University Of Miami Instrument for initiating an intralamellar channel
US5200462A (en) * 1991-01-25 1993-04-06 Eastman Kodak Company Succinimide containing polymers and lattices prepared from same
WO1992020721A1 (fr) * 1991-05-22 1992-11-26 Kao Corporation Procede pour produire une resine vinylique a base d'eau auto-dispersible et absorbant les ultraviolets, et une fine particule de celle-ci
US5276079A (en) * 1991-11-15 1994-01-04 Minnesota Mining And Manufacturing Company Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same
FR2691969B1 (fr) * 1992-06-04 1994-09-23 Prolabo Sa Nanoparticules de polymères fonctionnalisées, leur procédé de préparation et leur utilisation.
US5433745A (en) * 1993-10-13 1995-07-18 Allergan, Inc. Corneal implants and methods for producing same
AU1014695A (en) * 1994-02-17 1995-08-24 Collagen Corporation Collagen-synthetic polymer conjugates having controlled fiber size distributions
US6458889B1 (en) * 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
PT876165E (pt) * 1995-12-18 2006-10-31 Angiotech Biomaterials Corp Composicoes de polimeros reticulados e processos para a sua utilizacao
US6566406B1 (en) * 1998-12-04 2003-05-20 Incept, Llc Biocompatible crosslinked polymers
US6030634A (en) * 1996-12-20 2000-02-29 The Chinese University Of Hong Kong Polymer gel composition and uses therefor
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
JPH11189626A (ja) * 1997-12-26 1999-07-13 Unitika Ltd 温度応答型ハイドロゲル
US6103528A (en) * 1998-04-17 2000-08-15 Battelle Memorial Institute Reversible gelling culture media for in-vitro cell culture in three-dimensional matrices
AU3150400A (en) * 1999-01-25 2000-08-07 Biochip Technologies Gmbh Immobilization of molecules on surfaces via polymer brushes
DK1168934T3 (da) * 1999-04-12 2008-05-13 Cornell Res Foundation Inc Hydrogeldannende system med hydrofobe og hydrofile komponenter
JP2002542349A (ja) * 1999-04-16 2002-12-10 ダブリューエム・マーシュ・ライス・ユニバーシティー ポリ（プロピレンフマラート）−ジアクリレートマクロマーで交差結合された生体分解性のポリ（プロピレンフマラート）ネットワーク
US6803438B1 (en) * 1999-09-08 2004-10-12 Polytherics Limited Uniform molecular weight polymers
US6365171B1 (en) * 1999-11-04 2002-04-02 The University Of Akron Amphiphilic networks, implantable immunoisolatory devices and methods of preparation
CA2395456A1 (en) * 2000-01-05 2001-07-12 Novartis Ag Hydrogels
AU2001281485A1 (en) * 2000-03-23 2001-10-03 Genetics Institute, Inc. Thermoreversible polymers for delivery and retention of osteoinductive proteins
AR030341A1 (es) * 2000-08-14 2003-08-20 Novartis Ag Articulos biomedicos moldeados
JPWO2002039930A1 (ja) * 2000-11-17 2004-03-18 株式会社メニコン 医療用膜およびその製法、ならびにそれを用いた人工角膜およびその製法
JP4456291B2 (ja) * 2001-03-14 2010-04-28 日本化学工業株式会社 フルオロアルキル基含有オリゴマー類、その製造方法及び界面活性剤
JPWO2003006635A1 (ja) * 2001-07-13 2004-11-04 メビオール株式会社 細胞・組織培養用担体および培養方法

Also Published As

Publication number Publication date
EP1530600B1 (de) 2007-03-14
EP1741457A1 (de) 2007-01-10
CN1688622A (zh) 2005-10-26
AU2003254674A1 (en) 2004-02-25
JP2008093451A (ja) 2008-04-24
DE60312525T2 (de) 2007-12-06
ES2283849T3 (es) 2007-11-01
CN100491424C (zh) 2009-05-27
WO2004014969A1 (en) 2004-02-19
EP1530600A1 (de) 2005-05-18
US20150071871A1 (en) 2015-03-12
HK1078886A1 (zh) 2006-03-24
JP2006516038A (ja) 2006-06-15
MXPA05001570A (es) 2005-08-19
KR20050083626A (ko) 2005-08-26
DE60312525D1 (de) 2007-04-26
BR0313726A (pt) 2005-06-14
US20060246113A1 (en) 2006-11-02
US20060134050A1 (en) 2006-06-22
KR101053792B1 (ko) 2011-08-04

Similar Documents

Publication Publication Date Title
DE60312525D1 (de) Biosynthetische matrix und deren verwendung
Ramires et al. In vitro and in vivo biocompatibility evaluation of a polyalkylimide hydrogel for soft tissue augmentation
ES2152992T3 (es) Metodo para obtener un material bioerosionable para la liberacion sostenida de un medicamento, y el material obtenido del metodo.
MXPA03001914A (es) Matrices basadas en fibrina electroprocesada y tejidos.
DE60017956D1 (de) Biodegradierbare polymerzusammensetzung
MXPA01010692A (es) Matrices de proteina modificadas para ingenieria de tejidos o liberacion controlada.
EP0631499A4 (de) Material zur vermehrung von weichgewebe.
PL331703A1 (en) Sub- or intracutaneously injectable implant
IL161152A0 (en) Products for autologous implantation
DE602004029928D1 (de) Verwendung von alginat-matrizen zur kontrolle des zellwachstums
CA2467359A1 (en) Electroprocessed collagen
IT1307829B1 (it) Protesi dentale con mezzi per il rilascio di farmaci o fattorispecifici atti ad impedire l'insorgenza di infezioni e/o promuovere
DE69803065D1 (de) Zellkulturmatrix und biologisch abbaubare dreidimensionale matrix auf hyaluronsäurederivatbasis
AU2001270656A1 (en) Three-dimensional structure biocompatible polymer with communicating cells, preparation method and use in medicine and surgery
DE59504351D1 (de) Implantierbare formkörper zur verabreichung von wirkstoffen an pflanzen
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
BR0113106A (pt) Método para a produção de filmes à base de quitosan com capacidade de aderência celular acentuada, produto resultante e aplicações
Chavooshi et al. Cellulose and lignin-derived scaffold and their biological application in tissue engineering, drug delivery, and wound healing: a review
US9259445B2 (en) Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure
ATE398447T1 (de) Verwendung von ethanol als weichmacher zur herstellung von subkutanen implantaten , welche in einer plga matrize dispergierte thermolabile wirkstoffe enthalten
DE50013564D1 (de) Wirkstoff-beschichtete endoprothese mit langzeitstabilisierung
Shoichet et al. Polymers for tissue engineering
WO2003086290A3 (en) Electroprocessing of materials useful in drug delivery and cell encapsulation
ATE284424T1 (de) Funktionalisiertes polymer von glykosaminoglycan, arzneimittel und medizinische instrumente zu seiner herstellung
AU2148201A (en) Particulate construct for use in the transplantation field

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties